Posted by Michael Wonder on 12 Mar 2026
500,000 eligible to benefit from new non-hormonal treatment for hot flushes caused by menopause
11 March 2026 - A new treatment option for menopausal hot flushes and night sweats can be used in the NHS when hormone replacement therapy is not suitable.
Fezolinetant (Veoza, Astellas Pharma) is recommended to treat moderate to severe symptoms in final draft NICE guidance.
